Business Description
Genomic Valley Biotech Ltd
ISIN : INE574D01010
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.82 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 9.48 | |||||
Beneish M-Score | 13.8 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.2 | |||||
3-Year FCF Growth Rate | 40.3 | |||||
3-Year Book Growth Rate | -7.6 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 89.79 | |||||
9-Day RSI | 78.05 | |||||
14-Day RSI | 68.42 | |||||
6-1 Month Momentum % | 26.51 | |||||
12-1 Month Momentum % | 41.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.68 | |||||
Quick Ratio | 3.68 | |||||
Cash Ratio | 0.01 | |||||
Days Sales Outstanding | 4260.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 8.3 | |||||
Net Margin % | 9.21 | |||||
FCF Margin % | -12.17 | |||||
ROE % | 0.43 | |||||
ROA % | 0.29 | |||||
ROIC % | 0.31 | |||||
ROC (Joel Greenblatt) % | 0.62 | |||||
ROCE % | 0.43 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 764 | |||||
PE Ratio without NRI | 764 | |||||
Shiller PE Ratio | 999.5 | |||||
PS Ratio | 68.83 | |||||
PB Ratio | 3.29 | |||||
Price-to-Tangible-Book | 3.29 | |||||
EV-to-EBIT | 767.24 | |||||
EV-to-EBITDA | 719.88 | |||||
EV-to-Revenue | 70.64 | |||||
EV-to-FCF | -580.2 | |||||
Price-to-Graham-Number | 10.58 | |||||
Price-to-Net-Current-Asset-Value | 5.5 | |||||
Earnings Yield (Greenblatt) % | 0.13 | |||||
FCF Yield % | -0.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genomic Valley Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 1.651 | ||
EPS (TTM) (₹) | 0.05 | ||
Beta | 0.5 | ||
Volatility % | 51.4 | ||
14-Day RSI | 68.42 | ||
14-Day ATR (₹) | 2.140554 | ||
20-Day SMA (₹) | 31.637 | ||
12-1 Month Momentum % | 41.98 | ||
52-Week Range (₹) | 20.65 - 50.14 | ||
Shares Outstanding (Mil) | 3.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genomic Valley Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genomic Valley Biotech Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Genomic Valley Biotech Ltd Frequently Asked Questions
What is Genomic Valley Biotech Ltd(BOM:539206)'s stock price today?
When is next earnings date of Genomic Valley Biotech Ltd(BOM:539206)?
Does Genomic Valley Biotech Ltd(BOM:539206) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |